EVOLUÇÃO DE PACIENTES ONCOLÓGICOS COM DIAGNÓSTICO CONFIRMADO DE COVID 19 EM CENTRO DE REFERÊNCIA DE ALTA COMPLEXIDADE EM ONCOLOGIA

Abstract

The new coronavirus (SARS CoV 2019) gained notoriety after its spread in December 2019. Its disease, then called COVID-19 (coronavirus disease 2019), was declared a pandemic in March 2020. It is easily transmissible through droplets in the upper airways. , presents with flu-like symptoms (cough, sneeze, runny nose) and can be added to other manifestations such as diarrhea, fatigue, anosmia, dysgeusia, conjunctivitis, pharyngitis, fever and skin rashes. The diagnosis starts with clinical and epidemiological suspicion, being confirmed through tests with antigens, antibodies or polymerase chain reaction (PCR). Immersed in this scenario, cancer patients are vulnerable to contagion and the outcome of death, due to their inherent immunosuppression. In this sense, we aim to analyze the epidemiological profile of 5 the "death outcome" among cancer patients who obtained a confirmed diagnosis of COVID-19, through an observational, retrospective and descriptive study with a series of cases of cancer patients and COVID-19, seen at Napoleão Laureano Hospital, between March 2020 and February 2021. We hypothesize that these synchronous comorbidities result in high lethality